Risk factors for methicillin-resistant staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital

Public Health

Volumn 111, Issue 3, 1997, Pages 187-190

  Washio, M ^a,c   Mizoue, T ^b   Kajioka, T ^a   Yoshimitsu, T ^a   Okayama, M ^a   Hamada, T ^a   Yoshimura, T ^b   Fujishima, M ^c  

^a Imazu Sekijuji Hospital   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Activities of daily living (ADL); Albumin; Elderly; MRSA; Third generation cephalosporin

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CEPHEM; METICILLIN; MONOBACTAM; SERUM ALBUMIN;

AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CASE CONTROL STUDY; DAILY LIFE ACTIVITY; DRUG USE; FEMALE; GENDER; GERIATRIC HOSPITAL; HUMAN; HYPOALBUMINEMIA; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0030977042     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(97)00581-7     Document Type: Article

References (16)

1. Jevons MP. Celbenin-resistant Staphylococci, BMJ 1961; 1: 124-125.
2. Barret FF, McGehee RF, Finland M. Methicillin resistant Staphylococcus aureus at Boston City Hospital. N Engl J Med 1967; 279: 441-448.
3. Rountree PM, Beard M. Hospital strains of Staphylococcus aureus with particular resistance to methicillin-resistant strains. Med J Austr 1968; 2: 1163-1168.
4. Ichikawa A et al. Antibiotics resistance in Staphylococcus aureus, 1. Chemotherapy 1966; 141: 1-18 (in Japanese).
5. Yamaguchi K, Ohno A. Consideration on MRSA infections in relation to modern chemotherapy. Nihon Rinsho 1992; 50: 923-931 (in Japanese with English abstract).
6. Kono K et al. Methicillin-resistant Staphylococcus aureus (MRSA) isolated in hospitals in Fukuoka city area. Nihon Rinsho 1992; 50: 970-974 (in Japanese with English abstract).
7. Kajioka T et al. Methicillin-resistant Staphylococcus aureus (MRSA) infection in the elderly. J Epidemiol 1993; 3: 117-120.
8. Yoshimitsu T et al. Incidence of Methicillin-resistant Staphylococcus aureus (MRSA) isolation in a Geriatric Hospital: a second report on the risk factors for the occurrence of MRSA infection in the elderly. J Epidemiol 1994; 4: 129-132.
9. Washio M et al. Incidence of Methicillin-resistant Staphylococcus aureus (MRSA) isolation in a skilled nursing home: a third report on the risk factors for the occurrence of MRSA infection in the elderly. J Epidemiol 1996; 6: 69-73.
10. Washio M et al. Risk factors for Methicillin-resistant Staphylococcus aureus (MRSA) urinary tract infection in a geriatric hospital: a matched case control study. J Epidemiol 1995; 5: 95-98.
11. Reese RE, Betts RF. Handbook of Antibiotics, 2nd edn. Little Brown: Boston, 1993.
12. Kanno H. The detection of MRSA. Igaku No Ayumi 1993; 166: 302-305 (in Japanese).
13. SAS Institute Inc. SAS/STAT user' guide, release 6.03 edition. Cary, NC, 1988.
14. Boyce JM et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infect Control Hasp Epidemiol 1994; 15: 105-115.
15. Utsui Y, Yokota T, Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicob Agents Chemother 1985; 28: 379-403.
16. Tietz NW. Reference ranges and laboratory values of clinical importance. In: Wygaarden JB, Smith LH (eds). Cecil, Textbook of Medicine, 17th edn. WB Saunders Company, Philadelphia, 1982, 2320-2354.